How many ml are in a semaglutide pen, and does the volume matter?

Why a fixed 1.5 ml cartridge can deliver eight different dose strengths

The official prescribing information (published on the Electronic Medicines Compendium) confirms that every standard Wegovy pen is a 1.5 ml pre-filled multi-dose device, and if you have ever wondered how many ml are in a Wegovy pen and what that volume actually means in practice, the answer starts with understanding how concentration works across the different strengths. What the manufacturer adjusts between strengths is the milligrams of semaglutide per millilitre sitting in that cartridge. At 0.25 mg/dose, the concentration is lower; at 2.4 mg/dose, it is higher. The injected volume stays the same. That design choice is deliberate: a consistent injection volume means the subcutaneous tissue absorbs the solution predictably, and patients do not have to judge or adjust anything by eye.

This is not unique to Wegovy. Many pre-filled injection devices across different medicine classes work exactly this way — concentration varies, volume does not. It also means that trying to estimate your dose by looking at how much liquid is left in the pen is unreliable. Trust the dose counter, not the window.

For anyone reading the product labelling for the first time, the phrase "1.5 ml solution for injection" appears on the outer carton and refers to the cartridge fill. It is not a dosing instruction.

How four weekly injections come from one pen

Because each pen holds 1.5 ml and each injection delivers a fraction of that, one device provides four consecutive weekly doses before it should be discarded. The pen counts down from four to zero through a dose counter visible on the device. When the counter reaches zero, the pen is empty even if the window appears to show a little liquid, that residual volume is intentional overfill included by the manufacturer to ensure the final dose is complete.

The practical implication: you will use roughly one pen per month. Some people order just before a long bank holiday or a holiday abroad and worry about timing; worth thinking about whether your next pen will arrive before you travel. Our guide to how many injections are in each Wegovy pen covers the dose-counter mechanics in more detail, including what to do if you are unsure the last dose delivered fully.

Disposal matters too. Once a pen is finished, it should go into a sharps container rather than the household bin. This is not optional, it is a legal requirement for sharps waste in UK households, and used pens still carry a needle.

The 7.2 mg pen: a different device, same principle

On 14 April 2026 the MHRA approved a dedicated single-dose 7.2 mg Wegovy pen, one pre-set injection per week rather than four doses per cartridge. The MHRA's announcement describes an auto-dosing mechanism with a built-in covered needle that locks after use. The fill volume and concentration details for this format are set out in its own Patient Information Leaflet; the principle is the same (a pre-set amount you do not measure), but the device is not interchangeable with the standard multi-dose pen.

The 7.2 mg dose is the maximum licensed maintenance dose for Wegovy. Treatment still begins at 0.25 mg and titrates upward at roughly four-week intervals under a prescriber's direction; reaching 7.2 mg is a clinical decision, not an automatic end-point. Our overview of the Wegovy semaglutide pen range explains how the device formats differ across the titration schedule.

What the ml figure does not tell you about your treatment

Knowing that your pen holds 1.5 ml is useful background, but it does not tell you which strength is right for you, when to move to the next dose, or whether semaglutide is appropriate given your health history. Those are clinical questions. A good starting point for context on the full treatment picture is our Wegovy information page, which covers eligibility, the titration pathway and what to expect in the first weeks.

Semaglutide's trial evidence comes from the STEP programme. In STEP 1, published in the New England Journal of Medicine, adults using 2.4 mg weekly alongside lifestyle changes achieved an average weight reduction of around 15% over 68 weeks. None of that outcome depends on knowing the cartridge volume; it depends on consistent weekly use at the right dose, which a prescriber supervises.

It is also worth separating Wegovy from Ozempic, which is another semaglutide product but licensed for type 2 diabetes rather than weight management. Our explainer on Ozempic and weight loss sets out why the two are not interchangeable. If you are trying to understand your treatment options more broadly, the weight-loss treatment overview gives a plain-English summary of what is licensed and how the medicines compare. Cost is a common follow-up question; Wegovy pricing in the UK sets out what a legitimate private prescription typically involves.

If you are ready to find out whether you are clinically suitable, our prescribers review consultations the same day, a real clinician reads your answers, not a piece of software. Check your eligibility with a free consultation.